{
  "id": "5c8d0a980101eac870000008",
  "type": "summary",
  "question": "Which proteins are markers of HPV oncogenic activity?",
  "ideal_answer": "p16INK4a (p16) tumor-suppressor protein is a biomarker of human papillomavirus (HPV) oncogenic activity that has revealed a high rate of positivity in histological high-gade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 2 (HSIL/CIN2) lesions.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28811834",
    "http://www.ncbi.nlm.nih.gov/pubmed/18202795",
    "http://www.ncbi.nlm.nih.gov/pubmed/27739439",
    "http://www.ncbi.nlm.nih.gov/pubmed/16445657",
    "http://www.ncbi.nlm.nih.gov/pubmed/25708613"
  ],
  "snippets": [
    {
      "text": "Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16445657",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Using p16(INK4a) as a bio marker of HPV oncogenic activity, we demonstrate that the level of pRb dysfunction by high-risk HPV varied from subtypes and was getting more frequent from CIN2.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16445657",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While no stand-alone test was sufficiently accurate for classifying HPV-associated OPSCC, the high sensitivity and specificity of the established combination of p16 immunostain, DNA ISH, and HPV16 DNA amplification suggests that the introduction of labour- and cost-intensive mRNA ISH, is not necessary in the diagnostic routine of oropharyngeal tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25708613",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "p16INK4a (p16) tumor-suppressor protein is a biomarker of human papillomavirus (HPV) oncogenic activity that has revealed a high rate of positivity in histological high-gade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 2 (HSIL/CIN2) lesions.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27739439",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}